[go: up one dir, main page]

CN1931367A - Application of alginate in preparing medicine smell masking prepn - Google Patents

Application of alginate in preparing medicine smell masking prepn Download PDF

Info

Publication number
CN1931367A
CN1931367A CN 200610041579 CN200610041579A CN1931367A CN 1931367 A CN1931367 A CN 1931367A CN 200610041579 CN200610041579 CN 200610041579 CN 200610041579 A CN200610041579 A CN 200610041579A CN 1931367 A CN1931367 A CN 1931367A
Authority
CN
China
Prior art keywords
alginate
taste
application
masking
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610041579
Other languages
Chinese (zh)
Inventor
吕慧侠
周建平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN 200610041579 priority Critical patent/CN1931367A/en
Publication of CN1931367A publication Critical patent/CN1931367A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

本发明公开了海藻酸盐在制备掩盖药物不良异味的制剂中的应用。该应用是将需要掩味的药物采用不溶性的海藻酸盐包裹,制成口服制剂。采用该应用制备的制剂能有效掩盖药物不良异味,本发明提供的实现该应用的方法简单易行,适合工业化大生产。The invention discloses the application of alginate in the preparation of preparations for masking bad smell of medicines. The application is to encapsulate the drug that needs to be taste-masked with insoluble alginate to make an oral preparation. The preparation prepared by using the application can effectively cover the bad smell of the medicine, and the method for realizing the application provided by the invention is simple and easy, and is suitable for large-scale industrial production.

Description

海藻酸盐在制备掩盖药物不良异味的制剂中的应用Application of alginate in the preparation of preparations for masking bad smell of medicines

技术领域technical field

本发明属于医药领域,涉及海藻酸盐在制备掩盖药物不良异味的制剂中的应用。The invention belongs to the field of medicine and relates to the application of alginate in the preparation of preparations for masking the bad smell of medicines.

背景技术Background technique

很多的药物如多数无机盐、生物碱类、蛋白多肽类、大环内酯类抗生素、大蒜油等本身具有较强的苦味和异味,使得其在剂型开发及临床使用上受到了很大的限制。目前掩盖药物不良异味的方法一般来说有以下三种方法:(1)将药物结构进行改造,制备成无苦味的前体药物;(2)加入矫味剂、芳香剂、胶浆剂等掩盖苦味或麻痹味蕾,以达到掩味的目的;(3)采用制剂手段如包衣、包合、微囊等将药物与口腔粘膜上的味蕾隔开。Many drugs, such as most inorganic salts, alkaloids, protein polypeptides, macrolide antibiotics, garlic oil, etc., have strong bitterness and peculiar smell, which greatly restricts their formulation development and clinical use. . At present, there are generally three methods for covering the bad smell of drugs: (1) transforming the structure of the drug to prepare a non-bitter prodrug; (2) adding flavoring agents, fragrances, glues, etc. to cover Bitter or paralyzed taste buds, in order to achieve the purpose of taste masking; (3) use preparation methods such as coating, inclusion, microcapsules, etc. to separate the drug from the taste buds on the oral mucosa.

以下对现今制剂学上常用的两种掩盖药物苦味的方法进行比较:The following is a comparison of the two methods commonly used in pharmacy to mask the bitterness of drugs:

1、添加矫味剂:添加甜味剂、芳香剂、胶浆剂等辅料,用以麻痹味蕾或以甜味或香味掩盖苦味,此法需要加入较大量的矫味剂,方法虽然简单、但对较苦的药物作用有限,对于剂量较大的药物掩味效果也不佳。1. Adding flavoring agents: adding sweeteners, flavoring agents, mucilage and other auxiliary materials to numb the taste buds or cover up the bitterness with sweetness or fragrance. This method needs to add a large amount of flavoring agents. Although the method is simple, but It has limited effect on bitter drugs, and has poor taste-masking effect on drugs with large doses.

2、包衣:对药物粉末粒子进行包衣是掩盖苦味较有效的方法。目前常用有流化床包衣及相分离凝聚法。流化床包衣是常用的方法,一般需对粉末进行予处理,粉末太细可因静电作用凝集成团而影响包衣效果,而相分离凝聚法一般需要加入有机溶剂,工业化生产有一定难度。2. Coating: Coating the drug powder particles is a more effective method to mask the bitter taste. At present, fluidized bed coating and phase separation coagulation are commonly used. Fluidized bed coating is a commonly used method. Generally, the powder needs to be pre-treated. If the powder is too fine, it may agglomerate due to electrostatic interaction and affect the coating effect. The phase separation coagulation method generally requires the addition of organic solvents, which is difficult for industrial production. .

现有研究认为苦味药物分子中存在分子内氢键,即分子中有氢供给基和氢接受基,它们之间的距离(分子内氢键距离)在1.5A以内,使得药物疏水性增强。同时苦味药物分子中多含有其它疏水基团,这些基团易与苦味细胞的受体相结合(hydrophobicinteraction),对苦味细胞产生刺激作用,使人感觉到苦味。因此一般苦味物质的呈味阈值比酸、甜、咸味物质要低得多,即苦味物质容易吸附在苦味细胞受体膜上,使得其在很低的浓度下人体即能品尝到苦味。另外很多的苦味药物如生物碱类药物,在中性条件下大都带有正电荷,苦味受体膜表面带有负电荷,这样带正电荷的苦味物质就特别容易吸附于苦味受体膜上(electrostatic interaction),因此呈味阈值就非常低。Existing studies believe that there are intramolecular hydrogen bonds in bitter drug molecules, that is, there are hydrogen donor groups and hydrogen acceptor groups in the molecule, and the distance between them (intramolecular hydrogen bond distance) is within 1.5A, which enhances the hydrophobicity of the drug. At the same time, bitter drug molecules often contain other hydrophobic groups, and these groups are easy to combine with the receptors of bitter cells (hydrophobic interaction), which stimulates bitter cells and makes people feel bitter. Therefore, the taste threshold of general bitter substances is much lower than that of sour, sweet, and salty substances, that is, bitter substances are easily adsorbed on the bitter cell receptor membrane, so that the human body can taste bitterness at a very low concentration. In addition, many bitter drugs, such as alkaloids, are mostly positively charged under neutral conditions, and the surface of the bitter receptor membrane is negatively charged, so that positively charged bitter substances are particularly easily adsorbed on the bitter receptor membrane ( electrostatic interaction), so the taste threshold is very low.

海藻酸盐如海藻酸钠是一类从海带、马尾藻等藻类植物中提取出来的生物多糖类天然高分子化合物,是海藻细胞壁的主要成分,海藻酸经加工后,得到水溶性的海藻酸钠盐。海藻酸盐无毒、无刺激,且具有独特的理化性质和良好的生物相容性,被广泛应用于药物制剂、组织工程、临床治疗、细胞培养、食品加工等领域。大量研究表明海藻酸钠不仅是一种安全的食品添加剂,而且具有降脂、排除铅等重金属及抗肿瘤作用。在当今美国,海藻酸钠被誉为“奇妙的食品添加剂”;在日本被誉为“长寿食品”。目前海藻酸盐的需求量每年都在大幅增加,在各行业的应用也逐步扩大。Alginate such as sodium alginate is a kind of biological polysaccharide natural polymer compound extracted from algae plants such as kelp and sargassum. It is the main component of seaweed cell wall. After alginic acid is processed, water-soluble alginic acid is obtained sodium salt. Alginate is non-toxic, non-irritating, and has unique physical and chemical properties and good biocompatibility. It is widely used in pharmaceutical preparations, tissue engineering, clinical treatment, cell culture, food processing and other fields. A large number of studies have shown that sodium alginate is not only a safe food additive, but also has lipid-lowering, lead-free and anti-tumor effects. In the United States today, sodium alginate is known as a "wonderful food additive"; in Japan it is known as a "longevity food". At present, the demand for alginate is increasing substantially every year, and its application in various industries is gradually expanding.

海藻酸钠为白色或淡黄色粉末,其分子量高、呈线型、具有高水合性,在低浓度水溶液中就具有极高的粘度,分子中带有大量的羧基和羟基而带负电性,是很好的增稠剂、悬浮剂、填充剂、澄清剂、稳定剂及胶凝剂。海藻酸钠可与二价以上的金属离子络和交联,食品医药工业多用二价钙离子,生成的海藻酸钙具有水、酸不溶性,无毒且有足够的韧性强度。海藻酸钙凝胶可作为一种酶固定化、蛋白多肽类药物的口服给药以及缓控释给药的载体。海藻酸钙凝胶颗粒的制备方法主要有滴制法、浸渍法、反滴法、复合凝聚法等。而其中以滴制法操作最为简单,并且易于实现机械化工业的生产。Sodium alginate is a white or light yellow powder with high molecular weight, linear shape and high hydratability. It has extremely high viscosity in low-concentration aqueous solution. The molecule has a large number of carboxyl and hydroxyl groups and is negatively charged. Very good thickener, suspending agent, filler, clarifying agent, stabilizer and gelling agent. Sodium alginate can be complexed and cross-linked with metal ions above divalent, and divalent calcium ions are often used in the food and pharmaceutical industry. The resulting calcium alginate is insoluble in water and acid, non-toxic and has sufficient toughness and strength. Calcium alginate gel can be used as a carrier for enzyme immobilization, oral administration of protein and polypeptide drugs, and sustained and controlled release administration. The preparation methods of calcium alginate gel particles mainly include drop method, impregnation method, reverse drop method, composite coagulation method and so on. Among them, the drop method is the easiest to operate, and it is easy to realize the production of mechanized industry.

目前尚未有利用海藻酸盐对药物进行掩味的技术的报道。At present, there is no report on the technology of using alginate to mask the taste of drugs.

发明内容Contents of the invention

本发明的目的是在综合分析国内外掩盖药物苦味等不适性臭味的技术的基础上,提供了海藻酸盐在制备掩味剂中的应用,该应用的方法适合于工业化大生产。The purpose of the present invention is to provide the application of alginate in the preparation of taste-masking agent on the basis of comprehensive analysis of domestic and foreign technologies for masking unpleasant odors such as the bitter taste of medicines. The method of this application is suitable for large-scale industrial production.

本发明的目的是通过下列技术措施实现的:The purpose of the present invention is achieved through the following technical measures:

海藻酸盐在制备掩盖药物不良异味的制剂中的应用。Application of alginate in the preparation of preparations for masking bad odor of medicines.

所述的应用,该应用的方法是将需要掩味的药物采用不溶性的海藻酸盐包裹,制成口服制剂。Said application, the method of this application is to wrap the medicine that needs taste-masking with insoluble alginate to prepare oral preparation.

所述的应用,该方法是向可溶性的海藻酸盐溶液中加入需要掩味的药物,滴入含二价或二价以上金属离子的溶液充分反应,形成包裹了药物的不溶性海藻酸盐颗粒,过滤,干燥即可。Said application, the method is to add the drug that needs to be taste-masked to the soluble alginate solution, drop into the solution containing divalent or more than divalent metal ions to fully react, and form insoluble alginate particles wrapped with the drug, Filter and dry.

所述的应用,其中形成包裹了药物的不溶性海藻酸盐颗粒的方法采用滴制法、乳化法、浸渍法、反滴法、复合凝聚法、离心法、喷射法或喷雾冷凝法制备。Said application, wherein the method of forming the insoluble alginate particles wrapped with drugs is prepared by drop method, emulsification method, dipping method, reverse drop method, composite coacervation method, centrifugation method, spray method or spray condensation method.

所述的应用,其中可溶性的海藻酸盐是海藻酸钠、海藻酸钾中的一种或多种。Said application, wherein the soluble alginate is one or more of sodium alginate and potassium alginate.

所述的应用,其中不溶性的海藻酸盐是海藻酸钙。Said application, wherein the insoluble alginate is calcium alginate.

所述的应用,其中需要掩味的药物是大环内酯类抗生素、生物碱类药物、蛋白多肽类药物、具有刺激性异味的中药提取物。其中大环内酯类抗生素是阿齐霉素、罗红霉素或克拉霉素;生物碱类药物是盐酸小檗碱;蛋白多肽类药物是胃蛋白酶;具有强刺激性异味的中药提取物是大蒜油。In the above application, the drugs that need to be taste-masked are macrolide antibiotics, alkaloid drugs, protein polypeptide drugs, and traditional Chinese medicine extracts with pungent odors. Among them, macrolide antibiotics are azithromycin, roxithromycin or clarithromycin; alkaloid drugs are berberine hydrochloride; protein polypeptide drugs are pepsin; garlic oil.

所述的应用,其中口服制剂是颗粒剂、混悬剂、片剂、胶囊剂。Described application, wherein oral preparation is granule, suspension, tablet, capsule.

采用本发明成功地研制出罗红霉素、阿奇霉素、盐酸小檗碱、胃蛋白酶、大蒜油等掩味制剂。Taste-masking preparations such as roxithromycin, azithromycin, berberine hydrochloride, pepsin, garlic oil, etc. have been successfully developed by using the present invention.

按药物临床使用要求制成不同粒径颗粒后(载药量按药物占整个颗粒的重量百分比为5~95%、粒径:5μm~5mm),用于制备片剂、颗粒剂、混悬剂等各种口服剂型。According to the requirements of clinical use of drugs, particles of different particle sizes are made (drug loading is 5-95% by weight of the drug in the whole particle, particle size: 5μm-5mm), used to prepare tablets, granules, and suspensions and other oral dosage forms.

本发明的有益效果:Beneficial effects of the present invention:

1、本发明利用海藻酸盐可以包裹药物形成水、酸不溶性的海藻酸钙颗粒,将之应用于苦味等不良异味药物载药,一方面海藻酸盐分子中含的大量负电性基团可起到屏蔽苦味药物的正电荷,使之较少与味蕾的接触;另一方面海藻酸盐钙化后包裹药物,且由于海藻酸钙不溶于水,药物在口腔内的溶解量大大降低,可以减少药物与味蕾的接触,从而有效发挥掩味的作用。1. The present invention uses alginate to wrap drugs to form water- and acid-insoluble calcium alginate particles, which are applied to drug loading of bad smell drugs such as bitter taste. On the one hand, a large number of negatively charged groups contained in alginate molecules can act as To shield the positive charge of the bitter drug, so that it has less contact with the taste buds; on the other hand, the alginate is calcified to wrap the drug, and because the calcium alginate is insoluble in water, the amount of the drug dissolved in the oral cavity is greatly reduced, which can reduce the amount of the drug. The contact with the taste buds can effectively play the role of taste masking.

2、本发明提供的实现该应用的方法简单易行,适于工业化大生产。2. The method for realizing the application provided by the present invention is simple and feasible, and is suitable for large-scale industrial production.

具体实施方式Detailed ways

下面将描述本发明的几个实施例,但本发明的内容完全不限于此。Several embodiments of the present invention will be described below, but the content of the present invention is not limited thereto at all.

海藻酸钠样品来源:Sodium alginate sample source:

海藻酸钠样品1(220cps)、2(430cps)、3(530cps)-青岛胶南明月海藻工业有限公司提供;Sodium alginate samples 1 (220cps), 2 (430cps), 3 (530cps) - provided by Qingdao Jiaonan Mingyue Seaweed Industry Co., Ltd.;

海藻酸钠样品4(型号LVCR,粘度50cps)、5(型号DMB,粘度300cps)、6(型号HVCR,粘度400cps)、7(型号Kecosol,粘度1300cps)-国际特品提供(UK ISP Alginate Ltd)。Sodium alginate samples 4 (model LVCR, viscosity 50cps), 5 (model DMB, viscosity 300cps), 6 (model HVCR, viscosity 400cps), 7 (model Kecosol, viscosity 1300cps) - provided by International Special Products (UK ISP Alginate Ltd) .

以下实施例中溶出度及掩味效果采用下列方法:Dissolution and taste-masking effect adopt the following methods in the following examples:

溶出度:按2005版药典规定方法转篮法测定其所载药物溶出度,45分钟溶出在70%以上。Dissolution rate: According to the method specified in the 2005 edition of the Pharmacopoeia, the dissolution rate of the drug contained in it was measured by the basket method, and the dissolution rate was above 70% in 45 minutes.

掩味效果:将制备的掩味颗粒加入适量温水,一定时间点取样测定药物在水中的溶出浓度,是否在苦味浓度之下,30min后摇匀口服应无苦味或不适性臭味。Taste-masking effect: add the prepared taste-masking granules to an appropriate amount of warm water, take samples at a certain time point to measure the dissolution concentration of the drug in water, whether it is below the bitterness concentration, shake well after 30 minutes and take it orally, there should be no bitterness or unpleasant odor.

实施例1:阿奇霉素-海藻酸钙颗粒的制备,及苦味掩盖效果的考察。Example 1: Preparation of azithromycin-calcium alginate granules, and investigation of bitterness masking effect.

【滴制法制备阿奇霉素-海藻酸钙掩味颗粒】【Preparation of azithromycin-calcium alginate taste-masking granules by drop method】

将阿奇霉素混悬于1.5%海藻酸钠溶液中,在常温下用针头将混悬液滴入2%氯化钙溶液中,即可形成凝胶颗粒,将之钙化1小时后取出,过滤冲洗后干燥,得到的干燥颗粒待用。Suspend azithromycin in 1.5% sodium alginate solution, drop the suspension into 2% calcium chloride solution with a needle at room temperature to form gel particles, calcify it for 1 hour, take it out, filter and rinse Dry, and the resulting dry granules are ready for use.

【阿奇霉素苦味浓度的确定】【Determination of the Bitterness Concentration of Azithromycin】

将阿奇霉素制备成10%的浓度,加水稀释成不同浓度后,按浓到稀和稀到浓的不同顺序反复多人品尝,确定无苦味浓度。经测定,阿齐霉素的无苦味浓度为≤150μg/ml。Prepare azithromycin at a concentration of 10%, add water to dilute it to different concentrations, and repeatedly taste it with multiple people in different orders from thick to thin and thin to thick to determine the concentration without bitterness. After determination, the non-bitter taste concentration of azithromycin is ≤150 μg/ml.

【苦味掩盖效果考察】【Investigation on the masking effect of bitter taste】

将制备得到的干燥颗粒300mg(含药250mg)置于50ml去离子水中,5mmin,10min,30min取样,检测药物在水中的浓度并品尝30min后颗粒在口腔中的苦味,同时按照中国药典的方法测定药物在人工胃液(0.1M盐酸液)中的溶出度,见表1。Place 300mg of the prepared dry granules (containing 250mg of medicine) in 50ml of deionized water, take samples for 5mmin, 10min, and 30min, detect the concentration of the drug in the water and taste the bitter taste of the granules in the oral cavity after 30min, and measure according to the method of Chinese Pharmacopoeia See Table 1 for the dissolution rate of medicine in artificial gastric juice (0.1M hydrochloric acid solution).

表1阿齐霉素-海藻酸钙掩味颗粒在水中和人工胃液中的溶出情况。 样品   阿齐霉素-海藻酸钙掩味颗粒在水中的溶出浓度,μg/ml   阿齐霉素-海藻酸钙掩味颗粒在人工胃液中45min的溶出度   5min   10min   30min   30min后品尝   1234567   4.145.075.289.326.323.944.76   5.826.948.9211.099.024.597.93   11.0710.8315.3017.6414.749.0610.92   不苦不苦不苦不苦不苦不苦不苦   92%90%94%95%93%98%92% Table 1 Dissolution of azithromycin-calcium alginate taste-masking granules in water and artificial gastric juice. sample Dissolution concentration of azithromycin-calcium alginate taste-masking granules in water, μg/ml Dissolution of azithromycin-calcium alginate taste-masking granules in artificial gastric juice for 45 minutes 5min 10min 30min Taste after 30 minutes 1234567 4.145.075.289.326.323.944.76 5.826.948.9211.099.024.597.93 11.0710.8315.3017.6414.749.0610.92 No pain no pain no pain no pain no pain no pain 92% 90% 94% 95% 93% 98% 92%

观察以上实验数据,结果表明30min内,阿奇霉素从掩味颗粒中释放含量均远远低于苦味浓度,并且其在水中释放的药量与海藻酸钠型号、粘度等并无直接联系,在人工胃液中45min可溶出药物大于90%以上,说明其溶出度合格。说明运用滴制法制备得到的海藻酸钙含药凝胶颗粒具有良好的苦味掩蔽效果,并且能在胃内较快的溶出。Observing the above experimental data, the results show that within 30 minutes, the amount of azithromycin released from the taste-masking granules is far lower than the concentration of bitterness, and the amount of azithromycin released in water is not directly related to the type and viscosity of sodium alginate. The drug that can be dissolved in 45 minutes is more than 90%, indicating that its dissolution rate is qualified. It shows that the calcium alginate drug-containing gel particles prepared by the dropping method have good bitterness masking effect, and can dissolve quickly in the stomach.

实施例2:罗红霉素-海藻酸钙掩味颗粒的制备,及苦味掩盖效果的考察Example 2: Preparation of Roxithromycin-Calcium Alginate Taste-masking Granules, and Investigation of Bitter Taste Masking Effect

【滴制法制备罗红霉素-海藻酸钙掩味颗粒】【Preparation of roxithromycin-calcium alginate taste-masking granules by drop method】

将罗红霉素混悬于1.5%海藻酸钠溶液中(海藻酸钠与药物重量比为1∶6),常温下用针头将混悬液滴入2%氯化钙溶液中即可形成凝胶颗粒,钙化1小时后取出,过滤冲洗后干燥,得干燥颗粒备用。Suspend roxithromycin in 1.5% sodium alginate solution (the weight ratio of sodium alginate to drug is 1:6), drop the suspension into 2% calcium chloride solution with a needle at room temperature to form a gel Glue granules were taken out after calcification for 1 hour, filtered, rinsed and dried to obtain dry granules for later use.

【罗红霉素苦味浓度的确定】【Determination of Roxithromycin Bitterness Concentration】

将罗红霉素制备成10%的浓度,加水稀释成不同浓度后,按浓到稀和稀到浓的不同顺序反复多人品尝,确定无苦味浓度。经测定,罗红霉素的无苦味浓度为≤60μg/ml。Prepare roxithromycin at a concentration of 10%, add water to dilute it to different concentrations, and repeatedly taste it with multiple people in different orders from thick to thin and thin to thick to determine the concentration without bitterness. After determination, the non-bitter taste concentration of roxithromycin is ≤60 μg/ml.

【苦味掩盖效果考察】【Investigation on the masking effect of bitter taste】

将制备得到的干燥颗粒180mg(含药150mg)置于50ml去离子水中,5mmin,10min,30min取样,检测药物在水中的浓度并品尝30min后颗粒在口腔中的苦味,同时按照中国药典的方法测定药物在人工胃液(0.1M盐酸液)中的溶出度,见表2Place 180mg of the prepared dry granules (containing 150mg of medicine) in 50ml of deionized water, take samples for 5mmin, 10min, and 30min, detect the concentration of the drug in the water and taste the bitter taste of the granules in the oral cavity after 30min, and measure according to the method of the Chinese Pharmacopoeia The dissolution rate of medicine in artificial gastric juice (0.1M hydrochloric acid solution), see Table 2

表2罗红霉素-海藻酸钙掩味颗粒在水中和人工胃液中的溶出情况 样品   罗红霉素-海藻酸钙掩味颗粒在水中的溶出浓度,μg/ml   罗红霉素-海藻酸钙掩味颗粒在人工胃液中45min的溶出度   5min   10min   30min   30min后品尝   1234567   3.2810.046.003.061.643.283.60   3.6013.5412.226.222.186.123.60   12.1212.4817.4813.869.9418.3413.98   不苦不苦不苦不苦不苦不苦不苦   91%89%94%93%96%90%90% Table 2 Dissolution of roxithromycin-calcium alginate taste-masking granules in water and artificial gastric juice sample Dissolution concentration of roxithromycin-calcium alginate taste-masking granules in water, μg/ml Dissolution of roxithromycin-calcium alginate taste-masking granules in artificial gastric juice for 45 minutes 5min 10min 30min Taste after 30 minutes 1234567 3.2810.046.003.061.643.283.60 3.6013.5412.226.222.186.123.60 12.1212.4817.4813.869.9418.3413.98 No pain no pain no pain no pain no pain no pain 91% 89% 94% 93% 96% 90% 90%

观察以上实验数据,结果表明30min内,罗红霉素从掩味颗粒中释放含量均远远低于苦味浓度,并且其在水中释放的药量与海藻酸钠型号、粘度等并无直接联系,在人工胃液中45min可溶出药物大于90%以上。说明运用滴制法制备得到的海藻酸钙含药凝胶颗粒具有良好的苦味掩蔽效果,并且能在胃内较快的溶出。Observing the above experimental data, the results show that within 30 minutes, the release content of roxithromycin from the taste-masking granules is far lower than the bitterness concentration, and the amount of roxithromycin released in water is not directly related to the type and viscosity of sodium alginate. In the artificial gastric juice 45min, the drug can be dissolved more than 90%. It shows that the calcium alginate drug-containing gel particles prepared by the dropping method have good bitterness masking effect, and can dissolve quickly in the stomach.

实施例3:盐酸小檗碱-海藻酸钙掩味颗粒的制备,及苦味掩盖效果的考察Example 3: Preparation of Berberine Hydrochloride-Calcium Alginate Taste-masking Granules, and Investigation of Bitter Taste Masking Effect

【乳化法制备盐酸小檗碱-海藻酸钙掩味颗粒】[Preparation of berberine hydrochloride-calcium alginate taste-masking granules by emulsification method]

将盐酸小檗碱混悬于2.0%海藻酸钠溶液中(海藻酸钠与药物重量比为1∶1),常温下将混悬液加入到含有适量吐温80的液体石蜡中(混悬液与液体石蜡体积比为1∶4),磁力搅拌30min后,滴入2ml、2%氯化钙溶液,钙化3小时,静置1h将沉淀物取出,过滤冲洗去表面的油状物,干燥,得干燥颗粒备用。Suspend berberine hydrochloride in 2.0% sodium alginate solution (the weight ratio of sodium alginate and drug is 1:1), and add the suspension into liquid paraffin containing an appropriate amount of Tween 80 at normal temperature (suspension The volume ratio to liquid paraffin is 1:4), after magnetic stirring for 30 minutes, 2ml, 2% calcium chloride solution was added dropwise, calcified for 3 hours, the precipitate was taken out after standing for 1 hour, the oil on the surface was washed by filtration, and dried to obtain Dry granules for later use.

【盐酸小檗碱苦味浓度的确定】【Determination of bitterness concentration of berberine hydrochloride】

将盐酸小檗碱制备成10%的浓度,加水稀释成不同浓度后,按浓到稀和稀到浓的不同顺序反复多人品尝,确定无苦味浓度。经测定,盐酸小檗碱的无苦味浓度为≤50μg/ml。Prepare berberine hydrochloride at a concentration of 10%, add water to dilute it to different concentrations, and taste it repeatedly in different orders from thick to thin and thin to thick to determine the concentration without bitterness. It has been determined that the non-bitter taste concentration of berberine hydrochloride is ≤50 μg/ml.

【苦味掩盖效果考察】【Investigation on the masking effect of bitter taste】

将制备得到的干燥颗粒200mg(含药100mg)置于50ml去离子水中,5mmin,10min,30min取样,检测药物在水中的浓度并品尝30min后颗粒在口腔中的苦味,同时按照中国药典的方法测定药物在人工胃液(0.1M盐酸液)中的溶出度,见表2Put 200mg of the prepared dry granules (containing 100mg of medicine) in 50ml of deionized water, take samples for 5mmin, 10min, and 30min, detect the concentration of the drug in the water and taste the bitter taste of the granules in the oral cavity after 30min, and measure according to the method of Chinese Pharmacopoeia The dissolution rate of medicine in artificial gastric juice (0.1M hydrochloric acid solution), see Table 2

表3盐酸小檗碱-海藻酸钙掩味颗粒在水中和人工胃液中的溶出情况 样品   盐酸小檗碱-海藻酸钙掩味颗粒在水中的溶出浓度,μg/ml   盐酸小檗碱-海藻酸钙掩味颗粒在人工胃液中45min的溶出度   5min   10min   30min   30min后品尝   1234567   1.131.201.551.301.341.281.60   3.413.542.223.822.182.793.80   10.2311.189.3211.007.748.347.99   不苦不苦不苦不苦不苦不苦不苦   81%77%75%78%77%76%82% Table 3 Dissolution of berberine hydrochloride-calcium alginate taste-masking granules in water and artificial gastric juice sample Dissolution concentration of berberine hydrochloride-calcium alginate taste-masking granules in water, μg/ml Dissolution of berberine hydrochloride-calcium alginate taste-masking granules in artificial gastric juice for 45 minutes 5min 10min 30min Taste after 30 minutes 1234567 1.131.201.551.301.341.281.60 3.413.542.223.822.182.793.80 10.2311.189.3211.007.748.347.99 No pain no pain no pain no pain no pain no pain 81% 77% 75% 78% 77% 76% 82%

观察以上实验数据,结果表明30min内,盐酸小檗碱从掩味颗粒中释放含量均远远低于苦味浓度,在人工胃液中45min可溶出药物大于70%以上。说明运用乳化法制备得到的海藻酸钙含药掩味颗粒具有良好的苦味掩蔽效果,并且能在胃内较快的溶出。Observing the above experimental data, the results show that within 30 minutes, the release content of berberine hydrochloride from the taste-masking granules is far lower than the bitterness concentration, and the drug can be dissolved in the artificial gastric juice for 45 minutes is greater than 70%. It shows that the calcium alginate-containing drug-masking granules prepared by the emulsification method have a good bitterness masking effect and can dissolve quickly in the stomach.

实施例4:胃蛋白酶-海藻酸钙掩味颗粒的制备,及腥味掩盖效果的考察Example 4: Preparation of Pepsin-Calcium Alginate Taste-masking Granules, and Investigation of Odor Masking Effect

【喷射法制备胃蛋白酶-海藻酸钙掩味颗粒】【Preparation of pepsin-calcium alginate taste-masking granules by spraying method】

将胃蛋白酶混悬于1.5%海藻酸钠溶液中(海藻酸钠与药物重量比为1∶6),采用喷射装置,在常温下将混悬液喷入2%氯化钙溶液中即可形成颗粒,钙化1小时后取出,过滤冲洗后干燥,得干燥颗粒备用。Suspend pepsin in 1.5% sodium alginate solution (the weight ratio of sodium alginate to drug is 1:6), use a spraying device to spray the suspension into 2% calcium chloride solution at room temperature to form The granules were taken out after 1 hour of calcification, filtered, rinsed and then dried to obtain dry granules for later use.

【腥味掩盖效果考察】【Investigation on the masking effect of fishy smell】

将制备得到的颗粒250mg(含药200mg)置于50ml去离子水中,5mmin,10min,30min取样,品尝30min后颗粒在口腔中的腥味度,见表4所示。Place 250 mg of the prepared granules (containing 200 mg of medicine) in 50 ml of deionized water, take samples for 5 min, 10 min, and 30 min, and taste the fishy taste of the granules in the oral cavity after 30 min, as shown in Table 4.

表4胃蛋白酶-海藻酸钙掩味颗粒在水中的溶出情况 样品   品尝颗粒剂在不同时间后的异味   5min   15min   30min   123456   无腥味无腥味无腥味无腥味无腥味无腥味   无腥味无腥味无腥味无腥味无腥味无腥味   有稍许腥味有稍许腥味有稍许腥味有稍许腥味有稍许腥味有稍许腥味   7   无腥味   无腥味   有稍许腥味 Table 4 Dissolution of pepsin-calcium alginate taste-masking granules in water sample Taste the off-flavor of the granules over time 5min 15min 30min 123456 No fishy smell No fishy smell No fishy smell No fishy smell No fishy smell No fishy smell No fishy smell No fishy smell Slightly fishy Slightly fishy Slightly fishy Slightly fishy Slightly fishy 7 no fishy smell no fishy smell slightly fishy

观察以上实验数据,结果表明,胃蛋白酶颗粒剂在15min内品尝不到腥味,但在30min有稍许腥味。表明颗粒剂在十五分钟内口服无腥味,具有较好的掩味效果。Observing the above experimental data, the results showed that the pepsin granule could not taste fishy smell within 15 minutes, but had a little fishy smell within 30 minutes. It shows that the granule has no fishy smell when taken orally within 15 minutes, and has a good taste-masking effect.

实施例5:大蒜油-海藻酸钙掩味颗粒的制备,及臭味掩盖效果的考察Example 5: Preparation of Garlic Oil-Calcium Alginate Taste-masking Granules, and Investigation of Odor Masking Effect

【离心法制备大蒜油-海藻酸钙掩味颗粒】[Preparation of garlic oil-calcium alginate taste-masking granules by centrifugation]

将大蒜油混悬于2.0%海藻酸钠溶液中(海藻酸钠与大蒜油重量比为1∶2),常温下采用离心法,将混悬液甩入2%氯化钙溶液中即可形成颗粒,钙化1小时后取出,过滤冲洗后干燥,得干燥颗粒备用。Suspend garlic oil in 2.0% sodium alginate solution (the weight ratio of sodium alginate to garlic oil is 1:2), use centrifugation at room temperature, and throw the suspension into 2% calcium chloride solution to form The granules were taken out after 1 hour of calcification, filtered, rinsed and then dried to obtain dry granules for later use.

【腥味掩盖效果考察】【Investigation on the masking effect of fishy smell】

将制备得到的干燥颗粒500mg(含药300mg)置于50ml去离子水中,5mmin,10min,30min取样,品尝30min后颗粒在口腔中的臭味,见表5所示。Place 500 mg of the prepared dry granules (containing 300 mg of medicine) in 50 ml of deionized water, take samples for 5 min, 10 min, and 30 min, and taste the odor of the granules in the oral cavity after 30 min, as shown in Table 5.

表5大蒜油-海藻酸钙掩味颗粒在水中的溶出情况。 样品   品尝大蒜油-海藻酸钙掩味颗粒在不同时间后的臭味   5min   15min   30min   1234567   无臭味无臭味无臭味无臭味无臭味无臭味无臭味   无臭味无臭味无臭味无臭味无臭味无臭味无臭味   无臭味无臭味无臭味无臭味无臭味无臭味无臭味 Table 5 Dissolution of garlic oil-calcium alginate taste-masking particles in water. sample Taste the odor of garlic oil-calcium alginate taste-masking particles after different time 5min 15min 30min 1234567 No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor No Odor

观察以上实验数据,结果表明,大蒜油-海藻酸钙掩味颗粒在30min内品尝不到臭味。表明颗粒剂在三十分钟内口服无臭味,具有较好的掩味效果。Observing the above experimental data, the results show that the garlic oil-calcium alginate taste-masking particles cannot taste the odor within 30 minutes. It shows that the granule has no odor when taken orally within 30 minutes, and has a good taste-masking effect.

Claims (9)

1, the application of alginate in the preparation medicine smell masking preparation.
2, application according to claim 1, the method that it is characterized in that this application are that the medicine that will need taste masking adopts insoluble alginate parcel, make oral formulations.
3, application according to claim 2, it is characterized in that this method is to add the medicine that needs taste masking in the alginate solution of solubility, splash into and contain bivalence or the above metal ion solution of bivalence is fully reacted, the insoluble alginate granule of medicine has been wrapped up in formation, filter dry getting final product.
4, application according to claim 3 is characterized in that forming the particulate method of the insoluble alginate that has wrapped up medicine and adopts dropping preparation method, emulsion process, infusion process, anti-dripping method, complex coacervation, centrifuging, spurt method or spray condensation method preparation.
5, application according to claim 3, the alginate that it is characterized in that solubility are one or more in sodium alginate, the potassium alginate.
6,, it is characterized in that insoluble alginate is a calcium alginate according to claim 2 or 3 described application.
7,, it is characterized in that the Chinese medicine extract that needs the medicine of taste masking to be macrolide antibiotics, alkaloids medicament, protein and peptide drugs, has the zest abnormal flavour according to claim 2 or 3 described application.
8, application according to claim 7 is characterized in that macrolide antibiotics is azithromycin, Roxithromycin or clarithromycin; Alkaloids medicament is a berberine hydrochloride; Protein and peptide drugs is a pepsin; Chinese medicine extract with strong and stimulating abnormal flavour is an Oleum Bulbus Allii.
9, application according to claim 2 is characterized in that oral formulations is granule, suspensoid, tablet, capsule.
CN 200610041579 2006-09-15 2006-09-15 Application of alginate in preparing medicine smell masking prepn Pending CN1931367A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610041579 CN1931367A (en) 2006-09-15 2006-09-15 Application of alginate in preparing medicine smell masking prepn

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610041579 CN1931367A (en) 2006-09-15 2006-09-15 Application of alginate in preparing medicine smell masking prepn

Publications (1)

Publication Number Publication Date
CN1931367A true CN1931367A (en) 2007-03-21

Family

ID=37877489

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610041579 Pending CN1931367A (en) 2006-09-15 2006-09-15 Application of alginate in preparing medicine smell masking prepn

Country Status (1)

Country Link
CN (1) CN1931367A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105535147A (en) * 2015-12-30 2016-05-04 广西壮族自治区花红药业股份有限公司 Taste-improved Gegen Qinlian pills and preparation method
CN109105499A (en) * 2018-08-22 2019-01-01 山东省农业科学院农业资源与环境研究所 A kind of milk tea powder and preparation method thereof containing lucidum spore powder
KR20210033433A (en) * 2019-09-18 2021-03-26 정원구 Drug suspension for companion animals and method for manufacturing the same
CN114532463A (en) * 2022-03-08 2022-05-27 渤海水产股份有限公司 Seaweed compound, preparation method and application thereof, and fish culture feed

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105535147A (en) * 2015-12-30 2016-05-04 广西壮族自治区花红药业股份有限公司 Taste-improved Gegen Qinlian pills and preparation method
CN109105499A (en) * 2018-08-22 2019-01-01 山东省农业科学院农业资源与环境研究所 A kind of milk tea powder and preparation method thereof containing lucidum spore powder
CN109105499B (en) * 2018-08-22 2021-07-20 山东省农业科学院农业资源与环境研究所 A kind of milk tea powder containing Ganoderma lucidum spore powder and preparation method thereof
KR20210033433A (en) * 2019-09-18 2021-03-26 정원구 Drug suspension for companion animals and method for manufacturing the same
KR102530032B1 (en) * 2019-09-18 2023-05-09 정원구 Drug suspension for companion animals and method for manufacturing the same
CN114532463A (en) * 2022-03-08 2022-05-27 渤海水产股份有限公司 Seaweed compound, preparation method and application thereof, and fish culture feed
CN114532463B (en) * 2022-03-08 2023-12-22 渤海水产股份有限公司 Seaweed compound, preparation method and application thereof, and fish-farming feed

Similar Documents

Publication Publication Date Title
CN1606472A (en) Adsorbent for phosphoric acid
CN100337661C (en) Application of snake grape plants and its extracts in the preparation of medicines and health products
CN106924750B (en) Somalutide oral particle preparation and preparation method thereof
CN101317832B (en) Oral administration nano-drug administration system of resveratrol
CN1931367A (en) Application of alginate in preparing medicine smell masking prepn
CN1465285A (en) Lead-expelling health food and preparation method thereof
CN111718974A (en) Application of mung bean peptide in preparation of medicine for promoting lead excretion, active peptide and application thereof
CN100427096C (en) A kind of preparation method of salidroside nano liposome suspension
CN1217669C (en) Naringin used in preparing medicine for curing acute and chronic bronchitis
CN1857302A (en) Medicine for treating hyperphosphatemia and its preparing method
CN104645334B (en) N acetylcysteine activated carbon composites and its preparation method and application
CN103251557B (en) A kind of Felodipine nano suspension and preparation method thereof
CN108904519A (en) Hericium erinaceus Polysaccharides are in the purposes prepared in the drug for treating colitis and include its pharmaceutical composition
Arulanandraj et al. Nanotechnological approach to enhance the stability and bioavailability of the herbal drug “murva”
CN1278676C (en) Curcumin injection and method for preparing the same
CN1739686A (en) Chinese medicine injection for clearing away heat and toxic matter and its prepn process
CN1762341A (en) Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof
CN1911235A (en) Colon target prepn. contg. 5-aminosalicylic acid, and its prepn. method
CN1915324A (en) Pediatric Fupi preparation and preparation method thereof
CN119606889A (en) Composite polysaccharide microspheres capable of releasing NO and preparation method and application thereof
CN1840539A (en) Petrel saponin and its preparation method and use
CN1616024A (en) Shengmai powder injection and shengmai chewing tablet and its producing process
CN120360952A (en) A stable and efficient doxycycline hydrochloride soluble powder and preparation method thereof
WO2016015691A1 (en) A pharmaceutical composition having antibacterial and virucidal effects
CN1830458A (en) New uses of Tribulus terrestris extract

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20070321